
Work Here?
Molecule runs a decentralized biotech marketplace that connects scientists and researchers with investors to fund and advance novel research and intellectual property. Its platform tokenizes IP into IP-NFTs and enables the creation of Bio-DAOs, letting researchers raise funds and investors gain fractional ownership in early-stage biotech assets. The process works by packaging research projects as IP-NFTs and organizing collaborative governance through Bio-DAOs, with trades and funding occurring on a decentralized platform that charges transaction or onboarding fees. Molecule differentiates itself by embracing the DeSci trend, using tokenization and fractional ownership to streamline asset transfer, fundraising, and collaboration across the life sciences, rather than relying on traditional venture-backed rounds. The goal is to accelerate innovation in drug development and other scientific research by providing new funding avenues and a more open, efficient market for research assets.
Industries
Data & Analytics
Crypto & Web3
Financial Services
Biotechnology
Company Size
11-50
Company Stage
Seed
Total Funding
$20.5M
Headquarters
Berlin, Germany
Founded
2018
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$20.5M
Above
Industry Average
Funded Over
2 Rounds
Industry standards
Remote Work Options
Flexible Work Hours
Conference Attendance Budget
Professional Development Budget
Paid Vacation
Academic research is challenging. Obtaining grants and financial support for research projects is highly competitive and time-consuming. Researchers typically juggle multiple projects, including teaching, and they also have to deal with realities like data management and ethics.But now, a movement called Decentralised Science (DeSci) aims to transform traditional scientific research by connecting patients, scientists, investors, biotech DAOs, and novel crowdfunding methods. It democratises access to research funding through greater transparency, open access, and collaborative efforts, thus accelerating scientific breakthroughs.DeSci leverages blockchain-based platforms, tools, NFTs, tokens, decentralised autonomous organisations (DAOs), and Web3 principles to facilitate funding for scientific research.From online communities to open source bioscienceI spoke to a pioneer of the DeSci movement, Paul Kohlhaas, founder and Chief Architect at Molecule, a platform dedicated to accelerating scientific research and bringing intellectual property onchain through community-driven initiatives. It's like crowdfunding on steroids, where instead of getting an item in exchange for your funding, you get a cut of the intellectual property (IP).Kohlhaas spent his youth engaging with online biohacking forums and patient communities on platforms like Reddit, where online communities focused on tackling medical challenges—like diabetic patients collaborating to develop their own insulin due to its prohibitive cost in the US. From HIV communities exploring gene therapies to cancer patient groups sharing experimental treatments, nootropics and longevity, there was a community for virtually everything.He recalls:"What struck me was the collaborative and open spirit of these groups
The project also launched its new PLEX client that eases the burden of resource-intensive computations for scientific data.
If you are interested in creating a biotech DAO, Molecule is launching bio.xyz soon, a biotech DAO and DeSci launchpad - apply here for funding.
2) A new Intellectual Property primitive: Molecule has created a new legal primitive for intellectual property (IP) ownership called IP-NFTs that allows communities to invest in early stage research IP.
Northpond Ventures led the round that saw Molecule raise $13 million in seed capital. Backed VC and Shine Capital were also part of the round, as was Speedinvest, Speedinvest, and Balaji Srinivasan, former Coinbase CTO. This protocol views itself as part decentralized science, which is a movement that allows research projects to be owned and funded collectively.
Find jobs on Simplify and start your career today
Industries
Data & Analytics
Crypto & Web3
Financial Services
Biotechnology
Company Size
11-50
Company Stage
Seed
Total Funding
$20.5M
Headquarters
Berlin, Germany
Founded
2018
Find jobs on Simplify and start your career today